CTA
GSK icon

Chesley Taft & Associates’s GSK GSK Stock Holding History

Chesley Taft & Associates’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,065
Closed -$205K – 246
2014
Q2 		$205K Hold
3,065
– – 0.02% 241
2014
Q1 		$205K Hold
3,065
– – 0.02% 235
2013
Q4 		$205K Hold
3,065
– – 0.02% 258
2013
Q3 		$192K Buy
3,065
+80
+3% +$5.15K 0.02% 257
2013
Q2 		$186K Buy
+2,985
New +$189K 0.02% 256

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Chesley Taft & Associates's GSK Position: Q3 2014 in Review

Chesley Taft & Associates sold out of GSK (GSK) in Q3 2014, closing a stake of 3,065 shares — an estimated $205K sold.

Chesley Taft & Associates first reported a position in GSK in Q2 2013 and held it in 5 quarters. The position peaked at $205K in Q2 2014. 701 funds tracked by Wall St. Rank hold GSK as of Q3 2014.

  • Chesley Taft & Associates reported no remaining GSK position as of Q3 2014 after selling out during the quarter.
  • Chesley Taft & Associates sold 3,065 GSK shares in Q3 2014, an estimated $205K.
  • Chesley Taft & Associates first reported a position in GSK in Q2 2013 and held it in 5 quarters.
  • Chesley Taft & Associates's GSK position peaked at $205K in Q2 2014.
  • 701 funds tracked by Wall St. Rank held GSK as of Q3 2014.

Based on Chesley Taft & Associates's 13F filing for Q3 2014, filed 2 Oct 2014.